Log In
BCIQ
Print this Print this
 

catumaxomab (Removab)

  Manage Alerts
Collapse Summary General Information
Company Trion Pharma GmbH
DescriptionTrifunctional antibody targeting CD3 and epithelial cell adhesion molecule (EpCAM)
Molecular Target CD3 ; Epithelial cell adhesion molecule (EpCAM)
Mechanism of ActionBinds CD3; Binds epithelial cell adhesion molecule (EpCAM); Binds Fc gamma receptor I (CD64); Antibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/15/2013

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today